Cannabinoid Nanoemulsions Reduced Seizures Without Rescuing Memory in Mice
Cannabinoid nanoemulsions delayed seizures in mouse experiments without preventing deficits on the studied memory tasks. Antiseizure benefit and cognitive protection were separate outcomes, and the higher mixture dose did not consistently perform better.
Two experimental seizure models
Researchers administered oral CBD, THC or their combination before pentylenetetrazole, a chemical seizure challenge. They studied both acute seizures and repeated low-dose challenges used to produce kindling. Vehicle and a conventional antiseizure-drug comparison were included in the relevant experiments.
The investigation also assessed oxidative-stress and glial markers. It was not a trial in patients with spontaneous epilepsy.
The favorable findings have boundaries
Selected doses increased latency to generalized seizures and death and improved survival in the acute model. In the repeated-challenge experiment, CBD and lower combination doses delayed kindling, whereas the highest tested combination dose did not.
No cannabinoid treatment prevented the reported novel-object-recognition and Y-maze impairments. Changes in biochemical or glial markers therefore should not be described as proof that cognition was restored.
Formulation and translation
A nanoemulsion can change drug delivery, but superior bioavailability must be demonstrated with appropriate exposure measurements and comparisons. Smaller particles alone do not establish the complete causal explanation for efficacy.
The supplied article includes a republication notice for a minor change stated not to affect its scientific content. Its corrected version retains the distinction between seizure and cognitive outcomes.
For clinical interpretation, the specific model, pretreatment timing and dose matter. These results establish neither a human protective ratio nor a guarantee that a cannabis product improves memory while controlling seizures.
Related analysis
See our analysis of CBD in a distinct genetic epilepsy mouse model.
Primary research
Pedro Everson Alexandre de Aquino and colleagues. Nanoemulsions of Cannabidiol, Δ9-Tetrahydrocannabinol, and Their Combination Similarly Exerted Anticonvulsant and Antioxidant Effects in Mice Treated with Pentylenetetrazole. Pharmaceuticals. DOI: 10.3390/ph18060782.
